MAPT and Alzheimer disease: CSF tau 33/55 kDa ratio significantly decreased in patients with PSP (0.46 ± 0.16) when compared to healthy controls (p = 0.002), AD (P < 0.001), FTD, CBD, PD, and DLBD (values in PD similar to those of controls)